Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,728 | -32,698 | -22,899 | -11,914 | -51,659 |
| Depreciation Amortization | 3,510 | 2,616 | 1,707 | 833 | 2,591 |
| Accounts receivable | -560 | 398 | -1,164 | -383 | 2,900 |
| Accounts payable and accrued liabilities | -3,486 | -4,426 | -2,263 | -1,638 | 1,667 |
| Other Working Capital | -531 | -1,983 | -1,619 | -1,506 | 7,555 |
| Other Operating Activity | 8,621 | 7,414 | 5,842 | 3,248 | 1,011 |
| Operating Cash Flow | $-36,174 | $-28,679 | $-20,396 | $-11,360 | $-35,935 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 13,667 |
| PPE Investments | -1,646 | -1,489 | -1,391 | -1,023 | -12,996 |
| Investing Cash Flow | $-1,646 | $-1,489 | $-1,391 | $-1,023 | $671 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 39,698 | 39,698 | N/A | N/A | 14,383 |
| Debt Repayment | -2,418 | -2,017 | -1,341 | -589 | -6,138 |
| Common Stock Issued | 54 | N/A | N/A | N/A | 41,304 |
| Other Financing Activity | -15,000 | -15,000 | 0 | 0 | -3,416 |
| Financing Cash Flow | $22,334 | $22,681 | $-1,341 | $-589 | $46,133 |
| Beginning Cash Position | 35,324 | 35,324 | 35,324 | 35,324 | 24,455 |
| End Cash Position | 19,838 | 27,837 | 12,196 | 22,352 | 35,324 |
| Net Cash Flow | $-15,486 | $-7,487 | $-23,128 | $-12,972 | $10,869 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,174 | -28,679 | -20,396 | -11,360 | -35,935 |
| Capital Expenditure | -1,653 | -1,496 | -1,398 | -1,030 | -13,002 |
| Free Cash Flow | -37,827 | -30,175 | -21,794 | -12,390 | -48,937 |